Zobrazeno 1 - 10
of 47
pro vyhledávání: '"Gong, IY"'
Autor:
Gong, IY, Goodman, SG, Brieger, D, Gale, CP, Chew, DP, Welsh, RC, Huynh, T, DeYoung, JP, Baer, C, Gyenes, GT, Udell, JA, Fox, KAA, Yan, AT
Background: Although there are sex differences in management and outcome of acute coronary syndromes (ACS), sex is not a component of Global Registry of Acute Coronary Events (GRACE) risk score (RS) for in-hospital mortality prediction. We sought to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=core_ac_uk__::86dd1bd75fcd2f74bf1e34635c1c6fe5
https://eprints.whiterose.ac.uk/117951/1/1-s2.0-S0167527316347118-main.pdf
https://eprints.whiterose.ac.uk/117951/1/1-s2.0-S0167527316347118-main.pdf
Autor:
Tomlinson, BK, Thomson, JA, Bomalaski, JS, Diaz, M, Akande, T, Mahaffey, N, Li, T, Dutia, MP, Kelly, K, Gong, IY, Semrad, T, Gandara, DR, Pan, CX, Lara, PN
Publikováno v:
Tomlinson, BK; Thomson, JA; Bomalaski, JS; Diaz, M; Akande, T; Mahaffey, N; et al.(2015). Phase i trial of arginine deprivation therapy with ADI-PEG 20 plus docetaxel in patients with advanced malignant solid tumors. Clinical Cancer Research, 21(11), 2480-2486. doi: 10.1158/1078-0432.CCR-14-2610. UC Davis: Retrieved from: http://www.escholarship.org/uc/item/88q9k237
© 2015 AACR. Purpose: This phase I study examined the toxicity and tolerability of pegylated arginine deiminase (ADI-PEG 20) in combination with docetaxel in patients with advanced solid malignancies. Experimental Design: Eligible patients had histo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______325::bab2984c0d3032c38b2ae12c34e1b79d
http://www.escholarship.org/uc/item/88q9k237
http://www.escholarship.org/uc/item/88q9k237
Autor:
Gong IY; Princess Margaret Cancer Center Toronto Ontario Canada.; Division of Medical Oncology and Hematology University Health Network Toronto Ontario Canada., Tran D; Princess Margaret Cancer Center Toronto Ontario Canada.; Division of Medical Oncology and Hematology University Health Network Toronto Ontario Canada., Saibil S; Princess Margaret Cancer Center Toronto Ontario Canada.; Division of Medical Oncology and Hematology University Health Network Toronto Ontario Canada.; Department of Immunology University of Toronto Toronto Ontario Canada., Laister RC; Princess Margaret Cancer Center Toronto Ontario Canada.; Division of Medical Oncology and Hematology University Health Network Toronto Ontario Canada., Kuruvilla J; Princess Margaret Cancer Center Toronto Ontario Canada.; Division of Medical Oncology and Hematology University Health Network Toronto Ontario Canada.
Publikováno v:
HemaSphere [Hemasphere] 2024 Aug 22; Vol. 8 (8), pp. e130. Date of Electronic Publication: 2024 Aug 22 (Print Publication: 2024).
Autor:
Teh SH; From the The Permanente Medical Group, Gastric Cancer Surgery, Northern California, CA., Shiraga S; From the The Permanente Medical Group, Gastric Cancer Surgery, Northern California, CA., Kellem AM; The Permanente Consulting and Information Technology Group, Northern California, CA., Li RA; From the The Permanente Medical Group, Gastric Cancer Surgery, Northern California, CA., Le DM; From the The Permanente Medical Group, Gastric Cancer Surgery, Northern California, CA., Arsalane SP; From the The Permanente Medical Group, Gastric Cancer Surgery, Northern California, CA., Khayat FS; From the The Permanente Medical Group, Gastric Cancer Surgery, Northern California, CA., Li Y; The Permanente Medical Group, Gastrointestinal Oncology, Northern California, CA., Gong IY; The Permanente Medical Group, Gastrointestinal Oncology, Northern California, CA., Lee JM; From the The Permanente Medical Group, Gastric Cancer Surgery, Northern California, CA.
Publikováno v:
Annals of surgery open : perspectives of surgical history, education, and clinical approaches [Ann Surg Open] 2024 Mar 29; Vol. 5 (2), pp. e408. Date of Electronic Publication: 2024 Mar 29 (Print Publication: 2024).
Autor:
Gong IY; Department of Medicine, University of Toronto, Toronto, Ontario, Canada., Prica A; Department of Medicine, University of Toronto, Toronto, Ontario, Canada.; Institute for Clinical Evaluative Sciences, Toronto, Ontario, Canada.; Princess Margaret Cancer Centre, Toronto, Ontario, Canada., Ante Z; Institute for Clinical Evaluative Sciences, Toronto, Ontario, Canada., Calzavara A; Institute for Clinical Evaluative Sciences, Toronto, Ontario, Canada., Krzyzanowska MK; Department of Medicine, University of Toronto, Toronto, Ontario, Canada.; Institute for Clinical Evaluative Sciences, Toronto, Ontario, Canada.; Princess Margaret Cancer Centre, Toronto, Ontario, Canada., Singh S; Department of Medicine, University of Toronto, Toronto, Ontario, Canada.; Institute for Clinical Evaluative Sciences, Toronto, Ontario, Canada.; Sunnybrook Odette Cancer Centre, Toronto, Ontario, Canada., Suleman A; Department of Medicine, University of Toronto, Toronto, Ontario, Canada., Cheung MC; Department of Medicine, University of Toronto, Toronto, Ontario, Canada.; Institute for Clinical Evaluative Sciences, Toronto, Ontario, Canada.; Sunnybrook Odette Cancer Centre, Toronto, Ontario, Canada., Crump M; Department of Medicine, University of Toronto, Toronto, Ontario, Canada.; Princess Margaret Cancer Centre, Toronto, Ontario, Canada.
Publikováno v:
British journal of haematology [Br J Haematol] 2024 Mar; Vol. 204 (3), pp. 805-814. Date of Electronic Publication: 2023 Oct 27.
Autor:
Sheikh H; Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada., Walczak N; Department of Epidemiology and Biostatistics, University of Western Ontario, London, Ontario, Canada., Rana H; Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada., Tseng NWH; Lawrence S. Bloomberg Faculty of Nursing, University of Toronto, Toronto, Ontario, Canada., Syed MK; Faculty of Health Sciences, Ontario Tech University, Oshawa, Ontario, Canada., Collier C; Faculty of Health Sciences, Ontario Tech University, Oshawa, Ontario, Canada., Rezk M; Faculty of Health Sciences, Ontario Tech University, Oshawa, Ontario, Canada., Gong IY; Department of Medicine, University of Toronto, Toronto, Ontario, Canada., Tan NS; Division of Cardiology, Niagara Health System, Niagara, Ontario, Canada.; Department of Medicine, McMaster University, Hamilton, Ontario, Canada., Ali SH; Department of Medicine, St Mary's General Hospital, Toronto, Ontario, Canada., Yan AT; Department of Medicine, University of Toronto, Toronto, Ontario, Canada.; Terrence Donnelly Heart Centre, St. Michael's Hospital, Kitchener, Ontario, Canada., Randhawa VK; Department of Cardiovascular Medicine, Heart, Vascular and Thoracic Institute, Cleveland Clinic, Cleveland, Ohio, USA., Banks L; Faculty of Health Sciences, Ontario Tech University, Oshawa, Ontario, Canada.; Knowledge, Innovation, Talent, Everywhere (KITE), Toronto Rehabilitation Institute, University Health Network, Toronto, Ontario, Canada.
Publikováno v:
CJC open [CJC Open] 2023 Nov 02; Vol. 6 (2Part B), pp. 454-462. Date of Electronic Publication: 2023 Nov 02 (Print Publication: 2024).
Autor:
Gong IY; Department of Medicine, University of Toronto, Toronto, ON, Canada., Cheung MC; Department of Medicine, University of Toronto, Toronto, ON, Canada.; Sunnybrook Odette Cancer Centre, Toronto, ON, Canada.; Institute for Clinical Evaluative Sciences, Toronto, ON, Canada., Chan KKW; Department of Medicine, University of Toronto, Toronto, ON, Canada.; Sunnybrook Odette Cancer Centre, Toronto, ON, Canada.; Institute for Clinical Evaluative Sciences, Toronto, ON, Canada.; Canadian Centre for Applied Research in Cancer Control, Vancouver, BC, Canada., Arya S; Department of Medicine, University of Toronto, Toronto, ON, Canada., Faught N; Institute for Clinical Evaluative Sciences, Toronto, ON, Canada., Calzavara A; Institute for Clinical Evaluative Sciences, Toronto, ON, Canada., Liu N; Institute for Clinical Evaluative Sciences, Toronto, ON, Canada.; Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, ON, Canada., Odejide OO; Dana-Farber Cancer Institute, Boston, MA, USA., Abel G; Dana-Farber Cancer Institute, Boston, MA, USA., Kurdyak P; Institute for Clinical Evaluative Sciences, Toronto, ON, Canada.; Centre for Addition and Mental Health, Toronto, ON, Canada.; Department of Psychiatry, University of Toronto, Toronto, ON, Canada., Raphael MJ; Department of Medicine, University of Toronto, Toronto, ON, Canada.; Sunnybrook Odette Cancer Centre, Toronto, ON, Canada., Kuczmarski T; University of Washington Fred Hutchinson Cancer Center, Seattle, WA, USA., Prica A; Department of Medicine, University of Toronto, Toronto, ON, Canada.; Princess Margaret Cancer Centre, Toronto, ON, Canada., Mozessohn L; Department of Medicine, University of Toronto, Toronto, ON, Canada.; Sunnybrook Odette Cancer Centre, Toronto, ON, Canada.; Institute for Clinical Evaluative Sciences, Toronto, ON, Canada.
Publikováno v:
Journal of the National Cancer Institute [J Natl Cancer Inst] 2023 Oct 09; Vol. 115 (10), pp. 1194-1203.
Autor:
Gong IY; Department of Radiation Medicine, University of Toronto, Toronto, Ontario, Canada., Aminilari M; Radiation Medicine Program, Princess Margaret Cancer Centre, Toronto, Ontario, Canada., Landego I; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada., Hueniken K; Radiation Medicine Program, Princess Margaret Cancer Centre, Toronto, Ontario, Canada., Zhou Q; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada., Kuruvilla J; Department of Radiation Medicine, University of Toronto, Toronto, Ontario, Canada.; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada., Hodgson DC; Department of Radiation Medicine, University of Toronto, Toronto, Ontario, Canada.; Radiation Medicine Program, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.
Publikováno v:
Leukemia & lymphoma [Leuk Lymphoma] 2023 Oct; Vol. 64 (10), pp. 1643-1654. Date of Electronic Publication: 2023 Aug 07.
Autor:
Gong IY; Department of Medicine, University of Toronto, Toronto, ON, Canada., Chan KKW; Department of Medicine, University of Toronto, Toronto, ON, Canada.; ICES, Toronto, ON, Canada.; Odette Cancer Centre, Sunnybrook Health Sciences Center, Toronto, ON, Canada., Lipscombe LL; Department of Medicine, University of Toronto, Toronto, ON, Canada.; ICES, Toronto, ON, Canada.; Women's College Research Institute, Women's College Hospital, Toronto, ON, Canada., Cheung MC; Department of Medicine, University of Toronto, Toronto, ON, Canada.; ICES, Toronto, ON, Canada.; Odette Cancer Centre, Sunnybrook Health Sciences Center, Toronto, ON, Canada., Mozessohn L; Department of Medicine, University of Toronto, Toronto, ON, Canada. lee.mozessohn@sunnybrook.ca.; ICES, Toronto, ON, Canada. lee.mozessohn@sunnybrook.ca.; Odette Cancer Centre, Sunnybrook Health Sciences Center, Toronto, ON, Canada. lee.mozessohn@sunnybrook.ca.
Publikováno v:
British journal of cancer [Br J Cancer] 2023 Sep; Vol. 129 (4), pp. 665-671. Date of Electronic Publication: 2023 Jul 08.
Autor:
Gong IY; Department of Medicine, University of Toronto, Toronto, Ontario, Canada., Vijenthira A; Department of Medicine, University of Toronto, Toronto, Ontario, Canada.; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre-University Health Network, Toronto, Ontario, Canada., Powis M; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre-University Health Network, Toronto, Ontario, Canada.; Cancer Quality Lab (CQuaL), Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada., Calzavara A; ICES (formerly Institute for Clinical Evaluative Sciences), Toronto, Ontario, Canada., Patrikar A; ICES (formerly Institute for Clinical Evaluative Sciences), Toronto, Ontario, Canada., Sutradhar R; ICES (formerly Institute for Clinical Evaluative Sciences), Toronto, Ontario, Canada.; Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada., Hicks LK; Department of Medicine, University of Toronto, Toronto, Ontario, Canada.; Division of Hematology/Oncology, St Michael's Hospital-Unity Health, Toronto Ontario, Canada., Wilton D; ICES (formerly Institute for Clinical Evaluative Sciences), Toronto, Ontario, Canada., Singh S; Department of Medicine, University of Toronto, Toronto, Ontario, Canada.; ICES (formerly Institute for Clinical Evaluative Sciences), Toronto, Ontario, Canada.; Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada., Krzyzanowska MK; Department of Medicine, University of Toronto, Toronto, Ontario, Canada.; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre-University Health Network, Toronto, Ontario, Canada.; Cancer Quality Lab (CQuaL), Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.; ICES (formerly Institute for Clinical Evaluative Sciences), Toronto, Ontario, Canada., Cheung MC; Department of Medicine, University of Toronto, Toronto, Ontario, Canada.; ICES (formerly Institute for Clinical Evaluative Sciences), Toronto, Ontario, Canada.; Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.
Publikováno v:
JAMA oncology [JAMA Oncol] 2023 Mar 01; Vol. 9 (3), pp. 386-394.